Prevalence and determinants of diabetes mellitus in 2,338 long-term Dutch childhood cancer survivors (DCCS-LATER2 Study)

医学 队列 背景(考古学) 糖尿病 内科学 逻辑回归 队列研究 优势比 癌症 家族史 儿科 内分泌学 生物 古生物学
作者
Melissa Bolier,Demi T.C. de Winter,Marta Fiocco,Sjoerd A.A. van den Berg,Dorine Bresters,Eline van Dulmen‐den Broeder,Margriet van der Heiden‐van der Loo,Imo E. Hoefer,Geert O. Janssens,Leontien C. M. Kremer,Jacqueline J. Loonen,Marloes Louwerens,Heleen J. van der Pal,Saskia M.F. Pluijm,Wim J. E. Tissing,Hanneke M. van Santen,Andrica C. H. de Vries,Aart-Jan van der Lely,Marry M. van den Heuvel‐Eibrink,Sebastian Neggers
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [Oxford University Press]
标识
DOI:10.1210/clinem/dgaf078
摘要

Abstract Context/Objective Diabetes mellitus (DM), a possible adverse effect of childhood cancer treatment, is strongly associated with cardiovascular disease and early mortality in adult childhood cancer survivors (CCS). Here, we assess the prevalence and determinants of DM in our nationwide CCS cohort. Design/Methods In this cross-sectional study, the prevalence of DM was assessed in 2,338 CCS, using the Lifelines cohort (n=132,226 adults with no history of cancer) as a reference. DM was defined through serum glucose measurement (fasting glucose ≥7.0mmol/L or non-fasting ≥11.1mmol/L) and/or self-report (previous diagnosis and/or medication use). Multivariable logistic regression models, adjusted for age, sex, and BMI, were used to assess the cohort effect on the presence of DM. Multivariable logistic regression analysis was used to identify determinants of DM in CCS. Results Survivors (median age 34.7 years, median follow-up time 27.1 years) showed increased odds for hyperglycemia (aOR=2.72, 95%CI=2.06-3.59), previous DM diagnosis (aOR=3.03, 95%CI=2.33-3.95), and anti-diabetic medication use (aOR=2.94, 95%CI=2.17-3.99), compared to the reference cohort. Age (OR=4.32, 95%CI=1.84-10.15, >35 versus 18-35 years), BMI (OR=1.12, 95%CI=1.08-1.16, per point), family history of DM (OR=2.38, 95%CI=1.51-3.76), prior abdominal/pelvic radiotherapy (OR=4.19, 95%CI=2.32-7.55), total body irradiation (OR=14.31, 95%CI=6.98-29.34), hypogonadism (OR=2.40, 95%CI=1.15-4.99), hypertension (OR=1.71, 95%CI=1.06-2.76), and dyslipidemia (OR=3.81, 95%CI=2.15-6.75) were associated with DM in CCS. A significant interaction between age and sex on the development of DM in survivors was identified. Conclusions The identified three-fold increased risk of DM in CCS, along with the clinically relevant -and some modifiable- determinants, underscores the importance of early risk-based screening and the exploration of lifestyle interventions in this population.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
一日不看书智商输给猪完成签到,获得积分10
刚刚
sanshui410发布了新的文献求助10
1秒前
充电宝的应助被李悟尔采纳,获得10
1秒前
麦客完成签到,获得积分20
1秒前
张张完成签到,获得积分20
1秒前
molihuakai的应助被哒哒哒采纳,获得10
3秒前
丘比特的应助被哒哒哒采纳,获得10
3秒前
江宜完成签到 ,获得积分10
3秒前
3秒前
Ava的应助被哒哒哒采纳,获得10
3秒前
李健的小迷弟的应助被哒哒哒采纳,获得10
3秒前
田様的应助被哒哒哒采纳,获得10
4秒前
科目三的应助被哒哒哒采纳,获得10
4秒前
在水一方的应助被哒哒哒采纳,获得10
4秒前
Owen的应助被哒哒哒采纳,获得10
4秒前
小方发布了新的文献求助10
5秒前
12138发布了新的文献求助10
5秒前
哈哈哈发布了新的文献求助10
5秒前
赘婿的应助被binshier采纳,获得10
6秒前
大个的应助被一裤子灰采纳,获得10
6秒前
6秒前
7秒前
专属发布了新的文献求助10
7秒前
爆米花的应助被盐以律己采纳,获得10
8秒前
英俊的铭的应助被闭家锁采纳,获得10
9秒前
李小鱼发布了新的文献求助50
10秒前
kk完成签到,获得积分10
10秒前
丘比特的应助被嘻嘻采纳,获得10
10秒前
11秒前
daihia7发布了新的文献求助10
11秒前
AA发布了新的文献求助10
11秒前
fduqyy完成签到,获得积分10
12秒前
阿乐完成签到,获得积分10
13秒前
xldongcn完成签到 ,获得积分10
13秒前
13秒前
科研通AI2S的应助被Victor_CHou采纳,获得10
13秒前
15秒前
15秒前
16秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Composite Materials Handbook Volume 1 - Revision H 1000
Composite Materials Handbook Volume 3 - Revision H 1000
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7805524
求助须知:如何正确求助?哪些是违规求助? 9339206
关于积分的说明 20495093
捐赠科研通 7397861
什么是DOI,文献DOI怎么找? 3327889
关于科研通互助平台的介绍 2474667
邀请新用户注册赠送积分活动 2346007